Home         Forums  

Go Back   Marrowforums > Treatments > Drugs and Drug Treatments
Register FAQ Search Today's Posts Mark Forums Read

Drugs and Drug Treatments ATG, Cyclosporine, Revlimid, Vidaza, Dacogen, ...

Reply
 
Thread Tools Search this Thread
  #1  
Old Tue May 11, 2010, 05:57 AM
Birgitta-A Birgitta-A is offline
Member
 
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
More effective Vidaza in the future

Hi all,
Now the reseachers perhaps have found an azacytidine (Vidaza) variant with enhanced efficacy. Researchers believe that therapy resistance is frequently caused by the fact that not enough of Vidaza gets into the interior of the cells, because cancer cells lack particular transport molecules in the cell membrane.

A Norwegian company has produced an azacytidine variant with modified chemical properties. It is called CP-4200 and is a coupled product of azacytidine and a fatty acid (elaidic acid). When cancer cells in the culture dish are treated with CP-4200, the amount of methyltransferase molecules in the interior of the cells is reduced.
http://checkorphan.getreelhealth.com...nticancer-drug
Kind regards
Birgitta-A
Reply With Quote
  #2  
Old Tue May 11, 2010, 12:44 PM
Neil Cuadra Neil Cuadra is offline
Owner
 
Join Date: Jul 2006
Location: Los Angeles, California
Posts: 2,556
A number of websites picked up that dkfz press release. No word yet on what the next tests for CP-4200 will be.

From their description, it seems to me that the same technique (coupling the drug with a fatty acid) might improve efficacy with decitabine (Dacogen) too, because both are hypomethylating agents.
Reply With Quote
  #3  
Old Tue May 11, 2010, 02:35 PM
Birgitta-A Birgitta-A is offline
Member
 
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
Vidaza and Dacogen with

Hi Neil,
No, nothing about next step in those press releases but Dr Silverman and Dr Holland at Mount Sinai School of Medicine have a patent application called AZACYTIDINE ANALOGUES AND USES THEREOF dated 08-20-2009.

They write:"...The cytotoxic activity of 5-Aza-C-5'-elaidic acid was not only maintained but increased 50-fold when the hENT1 and hENT2 nucleoside transporters were blocked by the use of dipyridamole. The increased activity in cells where the nucleoside transporters are blocked by dipyridamole is surprising, and may indicate even higher activity in patients with resistance to treatment caused by lack of nucleoside transporters."

They seem to look at both Vidaza and Dacogen.
http://www.faqs.org/patents/app/20090209482
Kind regards
Birgitta-A
Reply With Quote
  #4  
Old Wed May 12, 2010, 11:05 PM
ann ann is offline
Member
 
Join Date: Aug 2009
Location: Burleson, TX
Posts: 77
Wonderful! Any news like this is so great for those who have not had good luck with the treatments they have been getting.
__________________
Ann, wife of Henry 73 year old diagnosed MDS, congestive heart disease and pulmonary edema..
Reply With Quote
  #5  
Old Thu Apr 12, 2012, 09:07 PM
tonydewitt tonydewitt is offline
Member
 
Join Date: Apr 2012
Location: NJ
Posts: 1
Cp-4200

Looks like that company is going at attached the fatty acid not only to Vizada (azacytidine becomes CP-4200), but also to Gemzar (gemcitabine becomes CP-4126). If their research is true, having the fatty acid attached to these known cancer drugs will improve their cellular uptake since they're less dependent on the nucleoside transporters, which supposedly improves their efficacy against various cancers. Hooray!
Reply With Quote
  #6  
Old Mon Apr 30, 2012, 08:59 AM
lfeinsmith lfeinsmith is offline
Member
 
Join Date: Oct 2007
Posts: 29
Which Treatment To Start

Quote:
Originally Posted by tonydewitt View Post
Looks like that company is going at attached the fatty acid not only to Vizada (azacytidine becomes CP-4200), but also to Gemzar (gemcitabine becomes CP-4126). If their research is true, having the fatty acid attached to these known cancer drugs will improve their cellular uptake since they're less dependent on the nucleoside transporters, which supposedly improves their efficacy against various cancers. Hooray!
Sounds interesting.
I just back from Md anderson .I have MDS since 2006 untreated.Now because my platelet count is lo 20000 and ANC is around 500-600 TREATMENT IS RECOMMENDED.
1) FIRST RECOMMENDATION DECABITINE (DACOGEN) 3 DAYS A WEEK
2) SECOND CHOICE IS AN ORAL FORM OF VIDAZA THIS WOULD BE PHASE 2 TRIAL WHICH STARTS IN AUGUST.

A CONFERENCE CALL IS SET UP FOR MONDAY THE 30TH APRIL (TODAY)
NO MENTION OF CP-4200
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Greg H - Vidaza as a Bridge to Transplant Greg H Transplants 54 Sun May 7, 2017 10:42 PM
Terrible Blood Counts after Vidaza joesmith MDS 11 Tue Aug 12, 2014 04:34 PM
When to stop Vidaza? Paolo D. Drugs and Drug Treatments 5 Sun Jun 26, 2011 03:15 AM
Vidaza Vs. Transplant Vera W MDS 18 Fri Apr 3, 2009 10:54 PM
Pharmion Applies for Vidaza Approval in Europe Marrowforums News and Events 0 Mon Jan 14, 2008 05:25 PM


All times are GMT -4. The time now is 07:47 PM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org